XML 41 R25.htm IDEA: XBRL DOCUMENT v3.5.0.2
Note 3 - Collaborative and Other Research and Development Contracts (Details Textual) - USD ($)
$ in Thousands
1 Months Ended 9 Months Ended 37 Months Ended
Jun. 16, 2015
Sep. 30, 2013
Feb. 28, 2006
Jun. 30, 2000
Sep. 30, 2016
Sep. 30, 2016
Mar. 31, 2015
Base Contract [Member]              
Government Contract Receivable             $ 16,265
Additional Development Options [Member]              
Government Contract Receivable             22,855
ASPRBARDA Contract [Member]              
Government Contract Receivable             $ 39,120
Proceeds from awards for Research and Development Contracts         $ 20,574    
Mundipharma [Member]              
Upfront Payments Receivable Amount     $ 10,000        
AECOM and IRL [Member]              
Milestone Payment Maximum       $ 4,000      
Milestone Payment Minimum       1,400      
Annual License Fee Minimum       150      
Annual License Fee Maximum       $ 500      
Advance Notice Period for Termination of Agreement       60 days      
National Institute of Allergy and Infectious Diseases [Member]              
Proceeds from awards for Research and Development Contracts   $ 5,000          
Expected Receivable From Awards for Research and Development Contracts           $ 39,477  
UAB [Member]              
Period of Agreement         25 years    
Renewable Period of Agreement         5 years    
CSL Limited [Member              
Proceeds from License Fees Received $ 33,740            
Milestone Payment Maximum $ 12,000            
Royalty Term 10 years